Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CARBIDOPA\LEVODOPA Cause Device issue? 2,574 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 2,574 reports of Device issue have been filed in association with CARBIDOPA\LEVODOPA. This represents 4.4% of all adverse event reports for CARBIDOPA\LEVODOPA.

2,574
Reports of Device issue with CARBIDOPA\LEVODOPA
4.4%
of all CARBIDOPA\LEVODOPA reports
193
Deaths
1,560
Hospitalizations

How Dangerous Is Device issue From CARBIDOPA\LEVODOPA?

Of the 2,574 reports, 193 (7.5%) resulted in death, 1,560 (60.6%) required hospitalization, and 39 (1.5%) were considered life-threatening.

Is Device issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CARBIDOPA\LEVODOPA. However, 2,574 reports have been filed with the FAERS database.

What Other Side Effects Does CARBIDOPA\LEVODOPA Cause?

Fall (7,132) Death (5,403) Dyskinesia (5,368) Tremor (3,689) General physical health deterioration (3,636) On and off phenomenon (3,509) Hallucination (3,367) Drug ineffective (3,205) Parkinson's disease (3,140) Device dislocation (2,937)

What Other Drugs Cause Device issue?

ADALIMUMAB (17,630) SOMATROPIN (5,131) PEGFILGRASTIM (5,071) ETANERCEPT (4,143) INSULIN GLARGINE (3,175) EXENATIDE (2,862) LEVONORGESTREL (2,623) GOLIMUMAB (1,827) USTEKINUMAB (1,716) EVOLOCUMAB (1,659)

Which CARBIDOPA\LEVODOPA Alternatives Have Lower Device issue Risk?

CARBIDOPA\LEVODOPA vs CARBIMAZOLE CARBIDOPA\LEVODOPA vs CARBOCYSTEINE CARBIDOPA\LEVODOPA vs CARBOMER CARBIDOPA\LEVODOPA vs CARBON DIOXIDE CARBIDOPA\LEVODOPA vs CARBON MONOXIDE

Related Pages

CARBIDOPA\LEVODOPA Full Profile All Device issue Reports All Drugs Causing Device issue CARBIDOPA\LEVODOPA Demographics